Modulating Inflammatory and Fibrogenic Pathways in Kidney Disease using a novel antagonist of Protease-Activated-Receptor-2

  • Nikolic-Paterson, David (Primary Chief Investigator (PCI))
  • Gobe, Glenda (Chief Investigator (CI))
  • Lohman, Rink-Jan (Chief Investigator (CI))
  • Suen, Jacky (Chief Investigator (CI))
  • Vesey, David (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/1531/12/17

Funding

  • National Health & Medical Research Council (NHMRC): AUD199,718.00